e-z cinnamic acid has been researched along with Inflammation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Hadjipavlou-Litina, D; Tsopka, IC | 1 |
| Athanasekou, C; Kourounakis, PN; Pantelidou, M; Papagiouvanis, G; Rekka, EA; Theodosis-Nobelos, P | 1 |
| Alkan, C; Balci Yuce, H; Gevrek, F; Isiker Kara, G; Karatas, O; Taskan, MM; Temiz, C | 1 |
| Barre, DE; Mizier-Barre, KA | 1 |
| Abozaid, OAR; Ahmed, ESA; Ibrahim, ZA; Moawed, FSM | 1 |
| Hadjipavlou-Litina, D; Pontiki, E | 1 |
| Aso, H; Donai, K; Fukuda, T; Isogai, E; Kasai, N; Katayama, M; Kodama, H; Kuroda, K; Miyagawa, M; Nishimori, K; Ohtomo, Y; Sakakibara, H; Sone, H; Suzuki, K; Uchida, T; Watanabe, K | 1 |
| Andrade, LN; de Cássia da Silveira E Sá, R; de Sousa, DP; Dos Reis Barreto de Oliveira, R | 1 |
| Kim, MJ; Rangasamy, S; Shim, Y; Song, JM | 1 |
3 review(s) available for e-z cinnamic acid and Inflammation
| Article | Year |
|---|---|
Hybrids as NO Donors.
Topics: Cinnamates; Humans; Inflammation; Nitric Oxide; Vasodilation | 2021 |
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy | 2020 |
A review on anti-inflammatory activity of phenylpropanoids found in essential oils.
Topics: Anti-Inflammatory Agents; Asthma; Biological Products; Cinnamates; Cytokines; Humans; Hypersensitivity; Immunomodulation; Inflammation; Oils, Volatile; Phenylalanine; Plants, Medicinal | 2014 |
6 other study(ies) available for e-z cinnamic acid and Inflammation
| Article | Year |
|---|---|
Design, Synthesis and Study of Nitrogen Monoxide Donors as Potent Hypolipidaemic and Anti-Inflammatory Agents.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carrageenan; Chromans; Cinnamates; Disease Models, Animal; Esterification; Inflammation; Lipid Peroxidation; Lipoxygenase; Molecular Structure; Nitric Oxide Donors; Rats | 2019 |
Cinnamic acid decreases periodontal inflammation and alveolar bone loss in experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Cinnamates; Female; Inflammation; Osteoclasts; Osteoprotegerin; Periodontitis; RANK Ligand; Rats; Rats, Wistar | 2020 |
Cinnamic acid nanoparticles modulate redox signal and inflammatory response in gamma irradiated rats suffering from acute pancreatitis.
Topics: Animals; Antioxidants; Apoptosis; Cinnamates; Inflammation; Male; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Mice; Nanoparticles; NF-kappa B; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Rats; Real-Time Polymerase Chain Reaction; Signal Transduction | 2020 |
Multi-Target Cinnamic Acids for Oxidative Stress and Inflammation: Design, Synthesis, Biological Evaluation and Modeling Studies.
Topics: Benzothiazoles; Biphenyl Compounds; Cinnamates; Hydroxyl Radical; Inflammation; Lipid Peroxidation; Lipoxygenase; Oxidative Stress; Picrates; Sulfonic Acids | 2018 |
Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the Long-Evans Cinnamon rat.
Topics: Adenosine Triphosphatases; Alanine Transaminase; Animals; Caffeine; Cation Transport Proteins; Cinnamates; Coffee; Copper; Copper-Transporting ATPases; Gene Expression; Glutathione Transferase; Hepatitis; Inflammation; Interleukin-6; Iron; Liver; Liver Neoplasms; Male; Oxidative Stress; Rats; Rats, Inbred LEC; RNA, Messenger; Smad2 Protein; Smad3 Protein; Tumor Necrosis Factor-alpha | 2014 |
Cell lysis-free quantum dot multicolor cellular imaging-based mechanism study for TNF-α-induced insulin resistance.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Aspirin; Cinnamates; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucose; Glycogen; Hep G2 Cells; Humans; Indomethacin; Inflammation; Insulin Receptor Substrate Proteins; Insulin Resistance; Molecular Imaging; Molecular Targeted Therapy; Protein Kinases; Quantum Dots; Reproducibility of Results; Serine; Tumor Necrosis Factor-alpha | 2015 |